CATHERINE FESSENDEN: Open Payments
NPI 1063949816 · AUBURN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Seqirus USA Inc | 1 | $41 |
| Novo Nordisk Inc | 2 | $39 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| GlaxoSmithKline, LLC. | 1 | $34 |
| Lilly USA, LLC | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $22 |
| Exact Sciences Corporation | 1 | $16 |
Products named: JARDIANCE, Flucelvax, Rybelsus, TRELEGY ELLIPTA, PREVNAR 20, MOUNJARO, TRUMENBA, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
